Cargando…

Neuroleptic malignant syndrome associated with COVID-19 vaccination

Detalles Bibliográficos
Autor principal: Nagamine, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678423/
https://www.ncbi.nlm.nih.gov/pubmed/34919205
http://dx.doi.org/10.1007/s43678-021-00254-0
_version_ 1784616305041604608
author Nagamine, Takahiko
author_facet Nagamine, Takahiko
author_sort Nagamine, Takahiko
collection PubMed
description
format Online
Article
Text
id pubmed-8678423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-86784232021-12-17 Neuroleptic malignant syndrome associated with COVID-19 vaccination Nagamine, Takahiko CJEM Letter Springer International Publishing 2021-12-17 2022 /pmc/articles/PMC8678423/ /pubmed/34919205 http://dx.doi.org/10.1007/s43678-021-00254-0 Text en © The Author(s), under exclusive licence to Canadian Association of Emergency Physicians (CAEP)/ Association Canadienne de Médecine d'Urgence (ACMU) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter
Nagamine, Takahiko
Neuroleptic malignant syndrome associated with COVID-19 vaccination
title Neuroleptic malignant syndrome associated with COVID-19 vaccination
title_full Neuroleptic malignant syndrome associated with COVID-19 vaccination
title_fullStr Neuroleptic malignant syndrome associated with COVID-19 vaccination
title_full_unstemmed Neuroleptic malignant syndrome associated with COVID-19 vaccination
title_short Neuroleptic malignant syndrome associated with COVID-19 vaccination
title_sort neuroleptic malignant syndrome associated with covid-19 vaccination
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678423/
https://www.ncbi.nlm.nih.gov/pubmed/34919205
http://dx.doi.org/10.1007/s43678-021-00254-0
work_keys_str_mv AT nagaminetakahiko neurolepticmalignantsyndromeassociatedwithcovid19vaccination